[{"country": "United States", "city": "Farmingdale", "address_1": "65 E Carmans Rd", "reason_for_recall": "Marketed without an Approved NDA/ANDA; product found to contain methasterone and dimethazine which are steroid and/or steroid-like drug ingredients, making it an unapproved new drug", "address_2": "", "product_quantity": "unknown", "code_info": "Lot numbers: C02R and F03Q", "center_classification_date": "20140305", "distribution_pattern": "Nationwide", "state": "NY", "product_description": "B-50 capsules, Healthy Life Chemistry By Purity First, packaged in 100 count bottles, Manufactured for: Purity First Health Products, Inc. dba Healthy Life Chemistry 51 Florida Street, Farmingdale, NY 11735", "report_date": "20140312", "classification": "Class I", "openfda": {}, "recalling_firm": "Mira Health Products Ltd.", "recall_number": "D-1149-2014", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "65772", "termination_date": "20140915", "more_code_info": "", "recall_initiation_date": "20130722", "postal_code": "11735-3834", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "69506", "recalling_firm": "Wockhardt Usa Inc.", "address_1": "20 Waterview Blvd., Suite 3", "address_2": "N/A", "postal_code": "07054", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide.", "recall_number": "D-0304-2015", "product_description": "Wockhardt  Metoprolol Succinate, Extended-Release Tablets USP, 50 mg,  a)100-count HDPE bottle (NDC 64679-735-02), b) 4000-count pack (64679-735-08), Manufactured by: Wockhardt Limited, Mumbai, India   Distributed by Wockhardt USA LLC. 20 Waterview Blvd. Parsippany, NJ 07054 USA .", "product_quantity": "1,118,400 extended release tablets", "reason_for_recall": "Failed Dissolution Specifications: Product was out of specification (OOS) at the 12 month long term stability testing point.", "recall_initiation_date": "20140417", "center_classification_date": "20141218", "termination_date": "20150813", "report_date": "20141224", "code_info": "a) Lot # LN10392; Exp. 12/14  b) Lot # LN10360; Exp. 12/14"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: MEXILETINE HCL, Capsule, 200 mg may have potentially been mislabeled as the following drug:  ISOSORBIDE DINITRATE, Tablet, 10 mg, NDC 00781155601, Pedigree: AD25264_1, EXP: 5/3/2014.", "address_2": "", "product_quantity": "100 Capsules", "code_info": "MEXILETINE HCL, Capsule, 200 mg has the following codes: Pedigree: AD25264_7, EXP: 5/3/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "MEXILETINE HCL, Capsule, 200 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00093874001.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-856-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "North Chicago", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA020517"], "brand_name": ["LUPRON DEPOT"], "generic_name": ["LEUPROLIDE ACETATE"], "manufacturer_name": ["AbbVie Inc."], "product_ndc": ["0074-3346", "0074-3473", "0074-3683", "0074-3642"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "spl_id": ["98a4f293-ee7c-44d0-9a1e-9dc7faf8aaf8"], "spl_set_id": ["cbc8f94e-7330-4465-05ad-16d64493a5dd"], "package_ndc": ["0074-3473-03", "0074-3683-03", "0074-3642-03", "0074-3346-03"], "is_original_packager": [true], "upc": ["300743642032"]}, "product_type": "Drugs", "event_id": "67709", "recalling_firm": "AbbVie Inc", "address_1": "1 N Waukegan Rd", "address_2": "", "postal_code": "60064", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-1291-2014", "product_description": "Lupron Depot (Leuprolide Acetate for Depot Suspension) Single Dose Administration Kit with prefilled dual-chamber syringe, 7.5 mg for 1-month administration, Rx only, Manufactured for: AbbVie Inc., North Chicago, IL  60064; by: Takeda Pharmaceutical Company Limited, Osaka, Japan 540-8645; NDC 0074-3642-03, UPC 3 00743 64203 2.", "product_quantity": "2915 kits", "reason_for_recall": "Defective Delivery System: Some Lupron Depot Kits may containin a syringe with a potentially defective LuproLoc needle stick protection device.", "recall_initiation_date": "20140310", "center_classification_date": "20140429", "termination_date": "20160622", "report_date": "20140507", "code_info": "Lot #: 1012381, 1012383, Exp 08/22/16", "more_code_info": ""}, {"status": "Terminated", "city": "Ferndale", "state": "WA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "67723", "recalling_firm": "Terra-Medica Inc.", "address_1": "1465 Slater Rd", "address_2": "N/A", "postal_code": "98248-8919", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Products were distributed US Nationwide, to Canada, to Philippines, and through internet sales.", "recall_number": "D-1212-2014", "product_description": "Pleo Stolo DROPS 6X, 10ml Bottle;  Homeopathic Anti-Inflammatory Medicine, OTC Only.  Made in Germany for: SANUM USA Copr, 1456 Slater Road, Ferndale, WA 98248 by Sanum-Kehlbeck GmbH & Co. KG. NDC: 49807-0011-1.", "product_quantity": "428 bottles", "reason_for_recall": "Penicillin Cross Contamination", "recall_initiation_date": "20140303", "center_classification_date": "20140407", "termination_date": "20140730", "report_date": "20140416", "code_info": "Batch # 08060; EXP: May 2015; Batch # 07119, EXP: August 2014; Batch # 03043, EXP: May 2018."}, {"status": "Terminated", "city": "Largo", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69250", "recalling_firm": "VistaPharm, Inc.", "address_1": "7265 Ulmerton Rd", "address_2": "", "postal_code": "33771-4809", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide, including Puerto Rico", "recall_number": "D-0010-2015", "product_description": "METOCLOPRAMIDE ORAL SOLUTION, USP 5 mg/5 mL, (present as the hydrochloride), 10 mL cups, Rx only. Manufactured by VistaPharm Inc., Largo, FL 33771. NDC 66689-031-01.", "product_quantity": "322,650 Cups", "reason_for_recall": "Defective Container: Product leaks when inverted.", "recall_initiation_date": "20140813", "center_classification_date": "20141009", "termination_date": "20150224", "report_date": "20141015", "code_info": "Lot #: 283700, Expiry: 11/14; Lot #: 291400, Expiry: 01/15; and Lot #: 303500, Expiry: 04/15.", "more_code_info": ""}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: VERAPAMIL HCL ER, Capsule, 240 mg may have potentially been mislabeled as the following drug:  FEBUXOSTAT, Tablet, 40 mg, NDC 64764091830, Pedigree: W002664, EXP: 6/5/2014.", "address_2": "", "product_quantity": "100 Capsules", "code_info": "VERAPAMIL HCL ER, Capsule, 240 mg has the following codes:   Pedigree: W002665, EXP: 6/5/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "VERAPAMIL HCL ER, Capsule, 240 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00378644001.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-908-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling:Label Mixup; BENAZEPRIL HCL Tablet, 5 mg may be potentially mislabeled as    ZINC SULFATE, Capsule, 220 mg, NDC 60258013101, Pedigree: AD52993_34, EXP: 5/20/2014.", "address_2": "", "product_quantity": "100 Tablets", "code_info": "BENAZEPRIL HCL Tablet, 5 mg has the following code    Pedigree: AD52778_7, EXP: 5/20/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "BENAZEPRIL HCL Tablet, 5 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 65162075110", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-712-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling:Label Mixup; ARIPiprazole Tablet, 2 mg may be potentially mislabeled as    tiZANidine HCl, Tablet, 2 mg, NDC 55111017915, Pedigree: AD21790_40, EXP: 5/1/2014;  ATOMOXETINE HCL, Capsule, 80 mg, NDC 00002325030, Pedigree: AD30140_19, EXP: 5/7/2014;  OLANZapine, Tablet, 7.5 mg, NDC 55111016530, Pedigree: AD46265_46, EXP: 5/15/2014;  REPAGLINIDE, Tablet, 2 mg, NDC 00169008481, Pedigree: AD464", "address_2": "", "product_quantity": "180 Tablets", "code_info": "ARIPiprazole, Tablet, 2 mg has the following codes    Pedigree: AD21790_43, EXP: 5/1/2014;  Pedigree: AD30140_25, EXP: 5/7/2014;  Pedigree: AD46265_19, EXP: 5/15/2014;  Pedigree: AD46414_1, EXP: 5/16/2014;  Pedigree: W003004, EXP: 6/11/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "ARIPiprazole Tablet, 2 mg, Rx only, Distributed by: AidaPak Service, LLC,  NDC 59148000613", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-639-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA075240"], "brand_name": ["LABETALOL HYDROCHLORIDE"], "generic_name": ["LABETALOL HYDROCHLORIDE"], "manufacturer_name": ["Hospira, Inc."], "product_ndc": ["0409-0125", "0409-2267"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["LABETALOL HYDROCHLORIDE"], "rxcui": ["896771"], "spl_id": ["54801b0d-200b-4df2-92f0-b5b787c4fb8b"], "spl_set_id": ["abfc6b75-1ed5-41f1-0484-4597488237bc"], "package_ndc": ["0409-2267-20", "0409-2267-54", "0409-0125-01", "0409-0125-25"], "is_original_packager": [true], "unii": ["1GEV3BAW9J"]}, "product_type": "Drugs", "event_id": "68296", "recalling_firm": "Hospira Inc.", "address_1": "275 N Field Dr", "address_2": "", "postal_code": "60045-2579", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-1424-2014", "product_description": "Labetalol Hydrochloride Injection, USP, 100 mg/20 mL (5 mg/mL), 20 mL Multidose Vial, packaged 50/20 mL glass vials/carton, Hospira, Inc., Lake Forest, IL 60045 --- NDC 0409-2267-20", "product_quantity": "45,448 vials", "reason_for_recall": "Presence of Particulate Matter; metal embedded in the glass vial and visible particles floating in the solution", "recall_initiation_date": "20140516", "center_classification_date": "20140708", "termination_date": "20170316", "report_date": "20140716", "code_info": "Lot 36225DD, exp 12/01/2015", "more_code_info": ""}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup; LUBIPROSTONE Capsule, 24 mcg may be potentially mislabeled as    ARIPiprazole, Tablet, 2 mg, NDC 59148000613, Pedigree: AD21790_43, EXP: 5/1/2014;  CYANOCOBALAMIN, Tablet, 1000 mcg, NDC 00904421713, Pedigree: AD21846_46, EXP: 5/1/2014;  VALSARTAN, Tablet, 160 mg, NDC 00078035934, Pedigree: AD39858_1, EXP: 5/16/2014.", "address_2": "", "product_quantity": "180 Capsules", "code_info": "LUBIPROSTONE Capsule, 24 mcg has the following codes    Pedigree: AD21790_46, EXP: 5/1/2014;  Pedigree: AD21811_1, EXP: 5/1/2014;  Pedigree: AD46312_1, EXP: 5/16/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "LUBIPROSTONE Capsule, 24 mcg, Rx only, Distributed by: AidaPak Service, LLC, NDC 64764024060", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-697-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: ACETAMINOPHEN/ BUTALBITAL/ CAFFEINE, Tablet, 325 mg/50 mg/40 mg may have potentially been mislabeled as the following drug:  ASPIRIN, Tablet, 325 mg, NDC 49348000123, Pedigree: W002640, EXP: 6/4/2014.", "address_2": "", "product_quantity": "100 Tablets", "code_info": "ACETAMINOPHEN/ BUTALBITAL/ CAFFEINE, Tablet, 325 mg/50 mg/40 mg has the following codes:   Pedigree:  W002654, EXP: 6/4/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "ACETAMINOPHEN/ BUTALBITAL/ CAFFEINE, Tablet, 325 mg/50 mg/40 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00603254421.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-982-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Edison", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA022362"], "brand_name": ["WELCHOL"], "generic_name": ["COLESEVELAM HYDROCHLORIDE"], "manufacturer_name": ["Daiichi Sankyo Inc."], "product_ndc": ["65597-902", "65597-701", "65597-903", "65597-209", "65597-210", "65597-208"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["COLESEVELAM HYDROCHLORIDE"], "rxcui": ["866900", "866903", "866905", "866907", "866910", "866912", "2123384", "2123387"], "spl_id": ["3e806127-4a87-41cc-9b17-a77e20bb2452"], "spl_set_id": ["4a06d3b2-7229-4398-baba-5d0a72f63821"], "package_ndc": ["65597-701-18", "65597-903-60", "65597-902-30", "65597-209-30", "65597-210-30", "65597-208-30"], "is_original_packager": [true], "upc": ["0365597902305"], "unii": ["P4SG24WI5Q"]}, "product_type": "Drugs", "event_id": "68793", "recalling_firm": "Daiichi Sankyo Pharma Development", "address_1": "399 Thornall St", "address_2": "", "postal_code": "08837-2236", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide", "recall_number": "D-1505-2014", "product_description": "Welchol Tablets (colesevelam HCl) 625 mg, 180 count bottles, Rx Only, Manufactured for: Daiichi Sankyo, Inc., Parsippany, NJ 07054 ---NDC 65597-701-18", "product_quantity": "68 bottles", "reason_for_recall": "Temperature Abuse; various products were not stored at Controlled Room Temperature as per USP guidelines during shipping", "recall_initiation_date": "20140712", "center_classification_date": "20140731", "termination_date": "20150316", "report_date": "20140806", "code_info": "Lot NVWG Exp - 11/30/2016", "more_code_info": ""}, {"status": "Terminated", "city": "Naperville", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69152", "recalling_firm": "Martin Avenue Pharmacy, Inc.", "address_1": "1247 Rickert Dr", "address_2": "N/A", "postal_code": "60540-1008", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0069-2015", "product_description": "Chorionic gonadotropin buffered diluent solution packaged in an amber glass injectable vial, Martin Avenue Pharmacy, 1247 Rickert Dr, Naperville, IL.", "product_quantity": "500 mL", "reason_for_recall": "Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of all compounded sterile preparations within expiry. The recall is being initiated in connection with a recent FDA inspection due to observations associated with certain quality control procedures that present a risk to sterility assurance.", "recall_initiation_date": "20140827", "center_classification_date": "20141029", "termination_date": "20180531", "report_date": "20141105", "code_info": "Lot Number: 03182014@24, Exp 9/14/2014; 04012014@31, Exp 9/28/2014; 06032014@30, Exp 11/30/2014; 07292014@28, Exp 1/25/2015", "more_code_info": ""}, {"country": "United States", "city": "Ft Lauderdale", "address_1": "1458 NW 23rd Ave", "reason_for_recall": "Marketed without an Approved NDA/ANDA: Laboratory analysis conducted by the FDA has determined that the products was found to contain sildenafil, an undeclared active pharmaceutical ingredient.", "address_2": "", "product_quantity": "", "code_info": "All lots", "center_classification_date": "20140320", "distribution_pattern": "Nationwide and France", "state": "FL", "product_description": "Clalis capsules, 50 mg, 6 -count bottle ( labeling is in foreign language)", "report_date": "20140326", "classification": "Class I", "openfda": {}, "recalling_firm": "Fabscout Entertainment, Inc", "recall_number": "D-1169-2014", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "65892", "termination_date": "20191002", "more_code_info": "", "recall_initiation_date": "20130627", "postal_code": "33311-5147", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "South Lyon", "address_1": "350 S Lafayette St", "reason_for_recall": "Lack of Assurance of Sterility: All unexpired sterile compounded human and veterinary products are being recalled because they were compounded in the same environment and under the same practices as another product found to be non-sterile and therefore sterility cannot be assured.", "address_2": "", "product_quantity": "5582.6 mL", "code_info": "All unexpired lots, manufactured and distributed between 07/01/2013 and 10/19/2013; including Lot #s: 09242013@8, 09242013@3, 09242013@4, 09242013@6, 09242013@7, 09242013@9, 10012013@1, 10012013@2, 10012013@3, 10012013@4, 10012013@5, 10012013@6, 10032013@6, 10142013@1", "center_classification_date": "20140110", "distribution_pattern": "Hospitals, clinics, physicians, and patients in the Michigan area only.", "state": "MI", "product_description": "Neomycin Sulfate* ophthalmic solution, 333 mg/mL, all sizes, Rx only, Specialty Medicine Compounding Pharmacy, 350 S Lafayette, South Lyon, MI 48178", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Specialty Medicine Compounding Pharmacy", "recall_number": "D-435-2014", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "66566", "termination_date": "20140922", "more_code_info": "", "recall_initiation_date": "20131019", "postal_code": "48178-1814", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Oklahoma City", "address_1": "755 Research Pkwy Ste 150", "reason_for_recall": "Marketed without an Approved NDA/ANDA: FDA has determined that the products are unapproved new drugs and misbranded.", "address_2": "", "product_quantity": "", "code_info": "all lot codes", "center_classification_date": "20140729", "distribution_pattern": "Nationwide", "state": "OK", "product_description": "Dermamedics Calm and Correct Cream 2 oz. containers in the Dermamedics Post Medical Procedure Kit with a SKU number of SK1005", "report_date": "20140806", "classification": "Class II", "openfda": {}, "recalling_firm": "Dermamedics, L.L.C.", "recall_number": "D-1493-2014", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "67247", "termination_date": "20170314", "more_code_info": "", "recall_initiation_date": "20140110", "postal_code": "73104-3621", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: FENOFIBRATE, Tablet, 54 mg may have potentially been mislabeled as the following drug:\t  FAMCICLOVIR, Tablet, 500 mg, NDC 00093811956, Pedigree: AD49448_4, EXP: 5/17/2014.", "address_2": "", "product_quantity": "90 Tablets", "code_info": "FENOFIBRATE, Tablet, 54 mg has the following codes:   Pedigree: AD49448_7, EXP: 5/17/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "FENOFIBRATE, Tablet, 54 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00115551110.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-860-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: DIGOXIN, Tablet, 0.125 mg may have potentially been mislabeled as one of the following drugs:   MELATONIN, Tablet, 3 mg, NDC 08770140813, Pedigree: AD21846_34, EXP: 5/1/2014;  DESMOPRESSIN ACETATE, Tablet, 0.1 mg, NDC 00591246401, Pedigree: AD46426_16, EXP: 5/15/2014;  PROPRANOLOL HCL, Tablet, 10 mg, NDC 00603548221, Pedigree: AD60264_1, EXP: 5/22/2014;  LIOTHYRONINE SODIUM,", "address_2": "", "product_quantity": "400 Tablets", "code_info": "DIGOXIN, Tablet, 0.125 mg has the following codes:   Pedigree: AD22609_4, EXP: 4/30/2014;  Pedigree: AD46426_22, EXP: 5/15/2014;  Pedigree: AD62829_8, EXP: 5/23/2014;  Pedigree: W003154, EXP: 6/13/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "DIGOXIN, Tablet, 0.125 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00115981101.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-861-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling:Label Mixup; ISOSORBIDE MONONITRATE Tablet, 10 mg may be potentially mislabeled as    ASCORBIC ACID, Tablet, 250 mg, NDC 00904052260, Pedigree: AD28322_10, EXP: 5/6/2014.", "address_2": "", "product_quantity": "100 Tablets", "code_info": "ISOSORBIDE MONONITRATE Tablet, 10 mg has the following code    Pedigree: AD28352_1, EXP: 5/7/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "ISOSORBIDE MONONITRATE Tablet, 10 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 62175010601", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-669-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Lewis Center", "address_1": "741 Radio Dr", "reason_for_recall": "Labeling: Label Mix up; product labeled as Morphine Sulfate 20 mg/mL actually contained OxyCODONE HCl 20 mg/mL", "address_2": "", "product_quantity": "55/1 mL/20mg/mL syringe", "code_info": "Lot #: 002HZI Use By: 7/20/2013 NDC: 00527-1426-36", "center_classification_date": "20140723", "distribution_pattern": "Product was shipped to the following states: CO, MA, OH, TX & WY.", "state": "OH", "product_description": "Oxycodone HCl Oral Concentrate, 20 mg/mL, Rx (C-II) Packaged and labeled as Morphine Sulfate 20 mg/mL, Mfg: Lannett Co. Inc., Re-Packaged By: Shamrock Medical Solutions Lewis Center, Ohio, Mfr: Cody Laboratories Inc., Cody, WY  NDC 00527-1426-36", "report_date": "20140730", "classification": "Class I", "openfda": {}, "recalling_firm": "Shamrock Medical Solutions Group LLC", "recall_number": "D-1447-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "64611", "termination_date": "20140731", "more_code_info": "", "recall_initiation_date": "20110927", "postal_code": "43035-7134", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Weston", "state": "FL", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "69170", "recalling_firm": "Apotex Corp.", "address_1": "2400 N Commerce Pkwy Ste 400", "address_2": "N/A", "postal_code": "33326-3253", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1570-2014", "product_description": "Candesartan Cilexetil and Hydrochlorothiazide Tablets 32 mg/12.5 mg, 90 count bottles, Rx only, Manufactured by: Apotex Research Pvt. Ltd. Bangalore - 560 099, India NDC 60505-3759-9", "product_quantity": "1,494 bottles", "reason_for_recall": "Failed Impurity/Degradation Specification; high out of specification for CAD II degradant", "recall_initiation_date": "20140821", "center_classification_date": "20140915", "termination_date": "20191002", "report_date": "20140924", "code_info": "Lot # KK6086, exp 03/2015, UPC 360505375998.", "more_code_info": ""}, {"status": "Terminated", "city": "North Wales", "state": "PA", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA076455"], "brand_name": ["VELIVET"], "generic_name": ["DESOGESTREL AND ETHINYL ESTRADIOL"], "manufacturer_name": ["Teva Pharmaceuticals USA, Inc."], "product_ndc": ["0555-9051"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "rxcui": ["654353", "729534", "748797", "759741", "759742", "762334"], "spl_id": ["855af598-bfc0-4f0b-ab61-d3cb414b86d5"], "spl_set_id": ["a3ce5125-62ba-4983-93f0-91f254271605"], "package_ndc": ["0555-9051-79", "0555-9051-67"], "is_original_packager": [true]}, "product_type": "Drugs", "event_id": "68610", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "1090 Horsham Rd", "address_2": "N/A", "postal_code": "19454-1505", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1439-2014", "product_description": "Velivet (desogestrel and ethinyl estradiol tablets - triphasic regimen),   0.1 mg/0.025 mg; 0.125 mg/0.025 mg; 0.15 mg/0.025 mg, 3 Dispensers x 28 Tablets, Barr Laboratories, Inc., Pomona, NY  NDC 0555-9051-67", "product_quantity": "5265 blister packs", "reason_for_recall": "Failed Impurities/Degradation Specifications: out of specification impurity test results.", "recall_initiation_date": "20140617", "center_classification_date": "20140717", "termination_date": "20150309", "report_date": "20140723", "code_info": "Lot 33805449A, Exp. 12/14"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: ENTECAVIR, Tablet, 0.5 mg may be potentially mis-labeled as one of the following drugs:  ARIPiprazole, Tablet, 2 mg, NDC 59148000613, Pedigree: AD30140_25, EXP: 5/7/2014;  aMILoride HCl, Tablet, 5 mg, NDC 64980015101, Pedigree: W003686, EXP: 6/26/2014;  ATOMOXETINE HCL, Capsule, 80 mg, NDC 00002325030, Pedigree: AD60272_49, EXP: 5/22/2014.", "address_2": "", "product_quantity": "90 Tablets", "code_info": "ENTECAVIR, Tablet, 0.5 mg has the following codes:   Pedigree: AD30140_28, EXP: 5/7/2014;  Pedigree: W003687, EXP: 6/26/2014;  Pedigree: AD60272_58. EXP: 5/22/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "ENTECAVIR, Tablet, 0.5 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00003161112.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-770-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Asheville", "address_1": "752 Biltmore Ave", "reason_for_recall": "Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.", "address_2": "", "product_quantity": "", "code_info": "All lot numbers within expiry.", "center_classification_date": "20140304", "distribution_pattern": "NC", "state": "NC", "product_description": "Novarel (IM)", "report_date": "20140312", "classification": "Class II", "openfda": {}, "recalling_firm": "Natures Pharmacy & Compounding Center", "recall_number": "D-1125-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "66856", "termination_date": "20140424", "more_code_info": "", "recall_initiation_date": "20131101", "postal_code": "28803-2558", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Lincoln", "address_1": "10401 Hwy 6", "reason_for_recall": "Failed Impurities/Degradation:Specifications:Unknown degradant found during stability testing.", "address_2": "", "product_quantity": "104,328/32-caplet packages", "code_info": "Lot # 10116279 exp 05/13   Lot # 10117810 exp 06/13   Lot # 10119274 exp 07/13  Lot # 10121463 exp 07/13", "center_classification_date": "20140116", "distribution_pattern": "Distribution was made nationwide and foriegn distribution was made--Mexicio, Panama, Ecuador and Venezuela.", "state": "NE", "product_description": "Maximum Strength Comtrex Day/Night Cold & Cough, Acetaminophen 325mg, Chlorpheniramine Maleate 2mg, Dextromethorphan HBR 10mg, Phenylephrine HCL 5mg,   packaged in 16 coated caplets daytime formula and 16 coated caplets nighttime formula *includes antihistamine Distributed by: Novartis Consumer Health, Inc., Parsippany, NJ 075054-0622,  NDC 0067-2082-32.", "report_date": "20140122", "classification": "Class III", "openfda": {}, "recalling_firm": "Novartis Consumer Health", "recall_number": "D-738-2014", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "65181", "termination_date": "20141104", "more_code_info": "", "recall_initiation_date": "20130515", "postal_code": "68517-9626", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {"application_number": ["NDA020936"], "brand_name": ["PAROXETINE HYDROCHLORIDE"], "generic_name": ["PAROXETINE HYDROCHLORIDE"], "manufacturer_name": ["Apotex Corp"], "product_ndc": ["60505-1316", "60505-1317", "60505-1318", "60505-3673", "60505-3674", "60505-3675"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["PAROXETINE HYDROCHLORIDE"], "rxcui": ["1738803", "1738805", "1738807"], "spl_id": ["f641c7b3-f7d2-9446-e589-074ac368853a"], "spl_set_id": ["087ff0d3-1761-47ea-a8c1-7c4cb679af97"], "package_ndc": ["60505-1316-3", "60505-1317-3", "60505-1318-3", "60505-3673-3", "60505-3674-3", "60505-3675-3"], "is_original_packager": [true], "upc": ["0360505367436", "0360505367535", "0360505367337"], "unii": ["X2ELS050D8"]}, "product_type": "Drugs", "event_id": "68967", "recalling_firm": "Apotex Inc.", "address_1": "150 Signet Drive", "address_2": "", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-1577-2014", "product_description": "Paroxetine HCL Controlled-Release Tablets 37.5 mg, 30-count bottle, Rx only, Manufactured by GlaxoSmithKline, RTP, NC 27709, Manufactured for Apotex Corp., Weston, FL 33328, NDC 60505-3675-3", "product_quantity": "", "reason_for_recall": "Chemical Contamination: Product were manufactured with active pharmaceutical ingredient (API) batches contaminated with residual materials and solvents.", "recall_initiation_date": "20140324", "center_classification_date": "20140903", "termination_date": "20140923", "report_date": "20140910", "code_info": "Lot # 2C002, Exp. 03/15  Lot # 2H004, Exp. 08/15  Lot # 2H006, Exp. 08/15", "more_code_info": ""}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup; NITROFURANTOIN MACROCRYSTALS Capsule, 50 mg may be potentially mislabeled as    PHYTONADIONE, Tablet, 5 mg, NDC 25010040515, Pedigree: AD25452_1, EXP: 4/30/2014.", "address_2": "", "product_quantity": "102 Capsules", "code_info": "NITROFURANTOIN MACROCRYSTALS, Capsule, 50 mg has the following code    Pedigree: AD25452_4, EXP: 5/3/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "NITROFURANTOIN MACROCRYSTALS Capsule, 50 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 47781030701", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-578-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: FOSINOPRIL SODIUM, Tablet, 10 mg may have potentially been mislabeled as the following drug:  MERCapsuleTOPURINE, Tablet, 50 mg, NDC 00054458111, Pedigree: AD54549_1, EXP: 5/20/2014.", "address_2": "", "product_quantity": "90 Tablets", "code_info": "FOSINOPRIL SODIUM, Tablet, 10 mg has the following codes:   Pedigree: AD54549_7, EXP: 5/20/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "FOSINOPRIL SODIUM, Tablet, 10 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00185004109.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-878-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling:Label Mixup; methylPREDNISolone Tablet, 4 mg may be potentially mislabeled as    LEVOTHYROXINE SODIUM, Tablet, 137 mcg, NDC 00781519192, Pedigree: AD22616_10, EXP: 5/2/2014.", "address_2": "", "product_quantity": "21 Tablets", "code_info": "methylPREDNISolone, Tablet, 4 mg has the following code    Pedigree: AD21811_17, EXP: 5/1/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "methylPREDNISolone Tablet, 4 mg, Rx only, Distributed by: AidaPak Service, LLC,  NDC 59746000103", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-642-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Miami", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA021514"], "brand_name": ["DAYTRANA"], "generic_name": ["METHYLPHENIDATE"], "manufacturer_name": ["Noven Therapeutics, LLC"], "product_ndc": ["68968-5552", "68968-5553", "68968-5554", "68968-5555"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["TRANSDERMAL"], "substance_name": ["METHYLPHENIDATE"], "rxcui": ["753436", "753437", "753438", "753439", "753440", "753441", "753442", "753443"], "spl_id": ["55f4b5f4-6d3c-4677-a94c-d47ffb59a91a"], "spl_set_id": ["2c312c31-3198-4775-91ab-294e0b4b9e7f"], "package_ndc": ["68968-5552-3", "68968-5553-3", "68968-5554-3", "68968-5555-3"], "is_original_packager": [true], "nui": ["N0000175739", "N0000175729"], "pharm_class_epc": ["Central Nervous System Stimulant [EPC]"], "pharm_class_pe": ["Central Nervous System Stimulation [PE]"], "unii": ["207ZZ9QZ49"]}, "product_type": "Drugs", "event_id": "67718", "recalling_firm": "Noven Pharmaceuticals, Inc.", "address_1": "11960 Sw 144th St", "address_2": "", "postal_code": "33186-6109", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide.", "recall_number": "D-1171-2014", "product_description": "Daytrana (methylphenidate) transdermal system patch, Delivers 20 mg over 9 hours (2.2mg/hr), 1 patch per pouch , packaged in 30-count patches per box, Rx Only. Manufactured for Noven Therapeutics, LLC, Miami, FL 33186, By Noven Pharmaceuticals, Inc., Miami, FL 33186.  NDC 68968-5554-3.", "product_quantity": "187,860 patches", "reason_for_recall": "Defective Delivery System: Out of Specification (OOS) results for the z-statistic value, which relates to the patients and caregiver ability to remove the release liner from the patch adhesive prior to administration, were obtained.", "recall_initiation_date": "20140213", "center_classification_date": "20140320", "termination_date": "20190319", "report_date": "20140326", "code_info": "Lot #69618, Exp. 09/14", "more_code_info": ""}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: DOCUSATE SODIUM, Capsule, 250 mg may have potentially been mislabeled as one of the following drugs:  PIOGLITAZONE, Tablet, 15 mg, NDC 00591320530, Pedigree: AD25452_10, EXP: 4/30/2014;  PHOSPHORUS, Tablet, 250 mg, NDC 64980010401, Pedigree: AD54498_1, EXP: 5/20/2014;  LACTOBACILLUS GG, Capsule, 0, NDC 49100036374, Pedigree: AD65457_16, EXP: 5/24/2014;  guaiFENesin ER, Table", "address_2": "", "product_quantity": "1204 Capsules", "code_info": "DOCUSATE SODIUM, Capsule, 250 mg has the following codes:   Pedigree: AD25452_13, EXP: 5/3/2014;  Pedigree: AD54498_4, EXP: 5/20/2014;  Pedigree: AD65457_19, EXP: 5/24/2014;  Pedigree: W003358, EXP: 6/19/2014;  Pedigree: W003558, EXP: 6/24/2014;  Pedigree: AD60211_11, EXP: 5/22/2014;  Pedigree: W003114, EXP: 6/13/2014;  Pedigree: AD37063_4, EXP: 5/13/2014;  Pedigree: AD73652_1, EXP: 5/29/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "DOCUSATE SODIUM, Capsule, 250 mg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00536375701.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-935-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Asheville", "address_1": "752 Biltmore Ave", "reason_for_recall": "Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.", "address_2": "", "product_quantity": "", "code_info": "All lot numbers within expiry.", "center_classification_date": "20140304", "distribution_pattern": "NC", "state": "NC", "product_description": "EDTA 3% ophthalmic", "report_date": "20140312", "classification": "Class II", "openfda": {}, "recalling_firm": "Natures Pharmacy & Compounding Center", "recall_number": "D-1111-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "66856", "termination_date": "20140424", "more_code_info": "", "recall_initiation_date": "20131101", "postal_code": "28803-2558", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Naperville", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69152", "recalling_firm": "Martin Avenue Pharmacy, Inc.", "address_1": "1247 Rickert Dr", "address_2": "N/A", "postal_code": "60540-1008", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0087-2015", "product_description": "Hydrochloric acid/water for injection 10% (w/v) packaged in an amber glass dropper bottle,  Martin Avenue Pharmacy, 1247 Rickert Dr, Naperville, IL.", "product_quantity": "90 mL", "reason_for_recall": "Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of all compounded sterile preparations within expiry. The recall is being initiated in connection with a recent FDA inspection due to observations associated with certain quality control procedures that present a risk to sterility assurance.", "recall_initiation_date": "20140827", "center_classification_date": "20141029", "termination_date": "20180531", "report_date": "20141105", "code_info": "Lot Number: 04252014@26, Exp 10/22/2014; 07092014@17, Exp 1/5/2015", "more_code_info": ""}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling:Label Mixup; METOPROLOL TARTRATE, Tablet, 25 mg may be potentially mislabeled as    ASCORBIC ACID, Tablet, 250 mg, NDC 00904052260, Pedigree: W003826, EXP: 6/27/2014;  amLODIPine BESYLATE, Tablet, 5 mg, NDC 00093716798, Pedigree: W002840, EXP: 6/7/2014.", "address_2": "", "product_quantity": "300 Tablets", "code_info": "METOPROLOL TARTRATE, Tablet, 25 mg has the following codes    Pedigree: W003843, EXP: 6/27/2014;  Pedigree: W002841, EXP: 6/7/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "METOPROLOL TARTRATE Tablet, 25 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 57664050652", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-629-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Baltimore", "state": "MD", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "67462", "recalling_firm": "Lupin Pharmaceuticals Inc.", "address_1": "111 S Calvert St Fl 21st", "address_2": "N/A", "postal_code": "21202-6174", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1186-2014", "product_description": "Suprax, Cefixime for Oral Suspension USP 500 mg/5 ml, 10mL (when reconstituted), Rx only, Manufactured for Lupin Pharmaceuticals, Inc. 111 South Calvert Street, Baltimore, MD 21202, Manufactured by Lupin Limited Mumbai 400 058 India, NDC 27437-207-02.", "product_quantity": "4,038 bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications: Product did not meet specification in total impurities at the 9-month stability station.", "recall_initiation_date": "20140127", "center_classification_date": "20140402", "termination_date": "20150512", "report_date": "20140409", "code_info": "Lot #s: F300737 Exp. February 2015, F300743 Exp. February 2015"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup; LISINOPRIL Tablet, 2.5 mg may be potentially mislabeled as    RANOLAZINE ER, Tablet, 500 mg, NDC 61958100301, Pedigree: AD23087_1, EXP: 5/2/2014;  DOCUSATE SODIUM, Capsule, 250 mg, NDC 00536375701, Pedigree: W003358, EXP: 6/19/2014.", "address_2": "", "product_quantity": "300 Tablets", "code_info": "LISINOPRIL Tablet, 2.5 mg has the following codes    Pedigree: AD25264_4, EXP: 5/3/2014;  Pedigree: W003365, EXP: 6/19/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "LISINOPRIL Tablet, 2.5 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 64679092701", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-692-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Radnor", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "66695", "recalling_firm": "Airgas Medical Services", "address_1": "259 N Radnor Chester Rd", "address_2": "St # 100", "postal_code": "19087-5240", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "To medical facilities in New Hampshire, Vermont, Massachusetts, and  New York.", "recall_number": "D-386-2014", "product_description": "Oxygen, Compressed USP, in an aluminum cylinder, Rx only, Airgas USA, LLC, Radnor PA 19087 Distributed by Keene Medical Products, 240 Meridian Road, NH 03766. NDC 11054-009", "product_quantity": "145 cylinders", "reason_for_recall": "Short Fill: Due to an error in the manufacturing process, cylinders in this lot may be empty and contain no medical oxygen.", "recall_initiation_date": "20131010", "center_classification_date": "20131223", "termination_date": "20140903", "report_date": "20140101", "code_info": "Lot # HS05A266E , size \"E\" and \"D\", NDC # 11054-009-XX  Number and Part Numbers = USPE, USPEAC, USPDAC", "more_code_info": ""}, {"status": "Terminated", "city": "Naperville", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69152", "recalling_firm": "Martin Avenue Pharmacy, Inc.", "address_1": "1247 Rickert Dr", "address_2": "N/A", "postal_code": "60540-1008", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0074-2015", "product_description": "Cyclosporine suspending vehicle packaged in an amber glass injectable vial, Martin Avenue Pharmacy, 1247 Rickert Dr, Naperville, IL.", "product_quantity": "180 mL", "reason_for_recall": "Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of all compounded sterile preparations within expiry. The recall is being initiated in connection with a recent FDA inspection due to observations associated with certain quality control procedures that present a risk to sterility assurance.", "recall_initiation_date": "20140827", "center_classification_date": "20141029", "termination_date": "20180531", "report_date": "20141105", "code_info": "Lot Number: 07032014@30, Exp 12/30/2014", "more_code_info": ""}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: PROPAFENONE HCL, Tablet, 150 mg may have potentially been mislabeled as the following drug:   FOSINOPRIL SODIUM, Tablet, 10 mg, NDC 00185004109, Pedigree: AD54549_7, EXP: 5/20/2014.", "address_2": "", "product_quantity": "100 Tablets", "code_info": "PROPAFENONE HCL, Tablet, 150 mg has the following codes:   Pedigree: AD54549_13, EXP: 5/20/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "PROPAFENONE HCL, Tablet, 150 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00591058201.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-966-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Horsham", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "67664", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "425 Privet Rd", "address_2": "N/A", "postal_code": "19044-1220", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide, Guam, Puerto Rico, American Samoa, Virgin Islands.", "recall_number": "D-1184-2014", "product_description": "Duloxetine Delayed-Release Capsules, USP, 60 mg, Rx Only, 30 Capsules per Bottle, Manufactured in Israel by: Teva Pharmaceutical IND, LTD, Jerusalem, Israel, Manufactured for: Teva Pharmaceuticals USA, Sellersville, PA, 18960, NDC 0093-7544-56", "product_quantity": "324,648 Bottles", "reason_for_recall": "Failed Tablet/Capsule Specifications: Teva Pharmaceuticals USA, is voluntarily recalling certain lots of Duloxetine DR Capsules USP, 20 mg, 30 mg & 60 mg due to a customer complaint trend regarding capsule breakage.", "recall_initiation_date": "20140304", "center_classification_date": "20140401", "termination_date": "20141112", "report_date": "20140409", "code_info": "Lot #: 50D003, Exp. 2/2015; 50D004, 50D005, Exp. 3/2015; 50D006, Exp. 5/2015; 50D010, Exp. 6/2015; 50D028, Exp. 9/2015; 50D029, 50D031, Exp. 10/2015; 50D032, 50D033, Exp. 11/2015"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup; CHOLECALCIFEROL, Tablet, 2000 units may be potentially mislabeled as     PYRIDOXINE HCL, Tablet, 50 mg, NDC 00904052060, Pedigree: AD46312_34, EXP: 5/16/2014;  PRENATAL MULTIVITAMIN/MULTIMINERAL, Tablet, NDC 13811051410, Pedigree: AD65314_1, EXP: 5/24/2014;  RANOLAZINE ER, Tablet, 500 mg, NDC 61958100301, Pedigree: W003538, EXP: 6/21/2014;  LEVOTHYROXINE SODIUM, Tablet, 175", "address_2": "", "product_quantity": "2,998 Tablets", "code_info": "CHOLECALCIFEROL, Tablet, 2000 units has the following codes    Pedigree: AD46312_37, EXP: 5/16/2014;  Pedigree: AD65311_1, EXP: 5/24/2014;  Pedigree: W003539, EXP: 6/21/2014;  Pedigree: W003744, EXP: 6/26/2014;  Pedigree: AD54586_10, EXP: 5/21/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "CHOLECALCIFEROL, Tablet, 2000 units, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00904615760", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-488-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Melrose Park", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA078052"], "brand_name": ["FOSPHENYTOIN"], "generic_name": ["FOSPHENYTOIN SODIUM"], "manufacturer_name": ["Fresenius Kabi USA, LLC"], "product_ndc": ["63323-403"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR", "INTRAVENOUS"], "substance_name": ["FOSPHENYTOIN SODIUM"], "rxcui": ["1670195", "1670200"], "spl_id": ["84385df0-4793-47d2-8e49-5c84668a0ba3"], "spl_set_id": ["b60c9c82-e5c7-4e05-98c7-5bbba4af04b2"], "package_ndc": ["63323-403-01", "63323-403-02", "63323-403-04", "63323-403-10"], "is_original_packager": [true], "upc": ["0363323403010", "0363323403041"], "unii": ["7VLR55452Z"]}, "product_type": "Drugs", "event_id": "68152", "recalling_firm": "Fresenius Kabi USA, LLC", "address_1": "2045 Cornell Ave", "address_2": "", "postal_code": "60160-1002", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-1429-2014", "product_description": "Fosphenytoin Sodium Injection, USP, 500 mg PE/10 mL (50 mg PE/mL), (PE= phenytoin sodium equivalents) 10 mL Single Use Vial, Rx only, Manufactured for APP Fresenius Kabi USA, LLC Lake Zurich, IL 60047, NDC 63323-403-10", "product_quantity": "728,880 vials", "reason_for_recall": "Presence of Particular Matter: Potential glass delamination and consistent with glass particulates observed in sample vials.", "recall_initiation_date": "20140502", "center_classification_date": "20140709", "termination_date": "20160524", "report_date": "20140716", "code_info": "Lot #  6003854; 04/14  6003855; 04/14  6004011; 05/14  6003961; 05/14  6004091; 06/14  6004092; 06/14  6004553; 08/14  6004554; 08/14  6004588; 09/14  6004589; 09/14  6005201; 12/14  6005202; 12/14  6005293; 12/14  6005294; 12/14  6005545; 02/15  6005546; 02/15  6005831; 03/15  6005832; 03/15  6005973; 04/15  6005974; 04/15  6006035; 05/15  6006036; 05/15  6006037; 05/15  6006174; 05/15  6006175; 05/15  6006176; 06/15  6006449; 07/15  6006450; 07/15  6006451; 07/15  6007168; 11/15", "more_code_info": ""}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA076477"], "brand_name": ["ATORVASTATIN CALCIUM"], "generic_name": ["ATORVASTATIN CALCIUM"], "manufacturer_name": ["Sun Pharmaceutical Industries Inc."], "product_ndc": ["63304-827", "63304-828", "63304-829", "63304-830"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ATORVASTATIN CALCIUM TRIHYDRATE"], "rxcui": ["259255", "617310", "617311", "617312"], "spl_id": ["24508d3d-eec0-4c5c-bfaa-d6e01a03fe80"], "spl_set_id": ["595ab888-6b55-4642-a32f-e8521821ed81"], "package_ndc": ["63304-827-90", "63304-827-05", "63304-828-90", "63304-828-05", "63304-829-90", "63304-829-05", "63304-830-90", "63304-830-05"], "is_original_packager": [true], "unii": ["48A5M73Z4Q"], "upc": ["633048279024"]}, "product_type": "Drugs", "event_id": "67485", "recalling_firm": "Ranbaxy Inc.", "address_1": "600 College Rd E Ste 2100", "address_2": "", "postal_code": "08540-6636", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1086-2014", "product_description": "Atorvastatin Calcium Tablets, 10 mg, 90-count tablets per bottle, Rx only, Manufactured for: Ranbaxy Pharmaceuticals Inc., Jacksonville, FL 32257 USA; by: Ranbaxy Laboratories Ltd., New Delhi -110 019, India; NDC 63304-827-90", "product_quantity": "64,626 bottles", "reason_for_recall": "Presence of Foreign Tablets: A product complaint was received by a pharmacist who discovered an Atorvastatin 20 mg tablet inside a sealed bottle of 90-count Atorvastatin 10 mg.", "recall_initiation_date": "20140116", "center_classification_date": "20140221", "termination_date": "20150114", "report_date": "20140305", "code_info": "2407255, 2407256 Exp. 05/14", "more_code_info": ""}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup; RIVAROXABAN Tablet, 20 mg may be potentially mislabeled as    VENLAFAXINE HCL, Tablet, 100 mg, NDC 00093738301, Pedigree: W002619, EXP: 6/4/2014.", "address_2": "", "product_quantity": "30 Tablets", "code_info": "RIVAROXABAN, Tablet, 20 mg has the following code    Pedigree: W002620, EXP: 6/4/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "RIVAROXABAN Tablet, 20 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 50458057930", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-596-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: CALCIUM CARBONATE/CHOLECALCIFEROL, Tablet, 600 mg/800 units may be potentially mis-labeled as the following drug:   REPAGLINIDE, Tablet, 1 mg, NDC 00169008281, Pedigree: AD52387_1, EXP: 5/17/2014.", "address_2": "", "product_quantity": "120 Tablets", "code_info": "CALCIUM CARBONATE/CHOLECALCIFEROL, Tablet, 600 mg/800 units has the following codes:   Pedigree: AD52993_1, EXP: 5/17/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "CALCIUM CARBONATE/CHOLECALCIFEROL, Tablet, 600 mg/800 units, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00005550924.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-773-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "South Lyon", "address_1": "350 S Lafayette St", "reason_for_recall": "Lack of Assurance of Sterility: All unexpired sterile compounded human and veterinary products are being recalled because they were compounded in the same environment and under the same practices as another product found to be non-sterile and therefore sterility cannot be assured.", "address_2": "", "product_quantity": "70 mL", "code_info": "All unexpired lots, manufactured and distributed between 07/01/2013 and 10/19/2013; including Lot #s: t08122013@18, t09232013@8", "center_classification_date": "20140110", "distribution_pattern": "Hospitals, clinics, physicians, and patients in the Michigan area only.", "state": "MI", "product_description": "HYDROXOCOBALAMIN* 10,000 mcg/mL INJECTABLE, Rx only, Specialty Medicine Compounding Pharmacy, 350 S Lafayette, South Lyon, MI  48178", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Specialty Medicine Compounding Pharmacy", "recall_number": "D-426-2014", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "66566", "termination_date": "20140922", "more_code_info": "", "recall_initiation_date": "20131019", "postal_code": "48178-1814", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Tulsa", "state": "OK", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69597", "recalling_firm": "Physicians Total Care, Inc.", "address_1": "12515 E 55th St Ste 106", "address_2": "N/A", "postal_code": "74146-6234", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed in Georgia and Missouri.", "recall_number": "D-0237-2015", "product_description": "CEPHALEXIN MONOHYDRATE CAPSULES,USP, 500 mg, 20-count bottle, Rx only, Manufactured for Caraco Pharmaceuticals, Detroit, MI 48202 by Sun Pharmaceuticals, Fort Worth, TX 76155 and repackaged by Physicians Total Care, Inc., Tulsa, OK 74146-6233", "product_quantity": "340 capsules (17 bottles containing 20 capsules each)", "reason_for_recall": "CGMP deviations: Products were manufactured with active pharmaceutical ingredients that were not manufactured with good manufacturing practices.", "recall_initiation_date": "20140922", "center_classification_date": "20141105", "termination_date": "20150316", "report_date": "20141112", "code_info": "Lot Code: 79MI (Exp. Date 01/31/2015), 79SF (Exp. Date 01/31/2015), 7AH5 (Exp. Date 06/30/2015)"}, {"status": "Terminated", "city": "North Wales", "state": "PA", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA075256"], "brand_name": ["APRI"], "generic_name": ["DESOGESTREL AND ETHINYL ESTRADIOL"], "manufacturer_name": ["Teva Pharmaceuticals USA, Inc."], "product_ndc": ["0555-9043"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "rxcui": ["240707", "748797", "749848", "753482"], "spl_id": ["06176d8d-c9e2-4912-ab6d-ecb3d5e514d8"], "spl_set_id": ["a9e08f9b-9862-4c2c-8302-53dc82d85126"], "package_ndc": ["0555-9043-79", "0555-9043-58"], "is_original_packager": [true]}, "product_type": "Drugs", "event_id": "68610", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "1090 Horsham Rd", "address_2": "N/A", "postal_code": "19454-1505", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1436-2014", "product_description": "Apri (desogestrel and ethinyl estradiol tablets USP), 0.15 mg/0.03 mg,  6 Cyclic dispensers X 28 tablets, Rx only, Teva Pharmaceuticals, Sellersville, PA. NDC 0555-9043-58", "product_quantity": "1104 blister packs", "reason_for_recall": "Failed Impurities/Degradation Specifications: out of specification impurity test results.", "recall_initiation_date": "20140617", "center_classification_date": "20140717", "termination_date": "20150309", "report_date": "20140723", "code_info": "Lot 3805324A  Exp. 11/14"}, {"status": "Terminated", "city": "Ferndale", "state": "WA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "67723", "recalling_firm": "Terra-Medica Inc.", "address_1": "1465 Slater Rd", "address_2": "N/A", "postal_code": "98248-8919", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Products were distributed US Nationwide, to Canada, to Philippines, and through internet sales.", "recall_number": "D-1195-2014", "product_description": "Pleo Not DROPS, 5X, 10 mL Bottles, Oral Homeopathic Medicine, OTC Only. Made in Germany, Distributed by: SANUM USA Corp.,1465 Slater Road, Fernadale, WA 98248;  Manufactured By: SANUM-Kehlbeck GmbH & Co. KG. NDC: 49807-2301-1.", "product_quantity": "21,445 Bottles", "reason_for_recall": "Penicillin Cross Contamination", "recall_initiation_date": "20140303", "center_classification_date": "20140407", "termination_date": "20140730", "report_date": "20140416", "code_info": "Batch # 21049, EXP: March 2014; Batch # 13059; EXP: April 2014; Batch # 09080, EXP: July 2015; Batch #15100; EXP: September 2015;  Batch # 24092; EXP: August 2017."}, {"status": "Terminated", "city": "Deerfield", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA019904"], "brand_name": ["POTASSIUM CHLORIDE"], "generic_name": ["POTASSIUM CHLORIDE"], "manufacturer_name": ["Baxter Healthcare Corporation"], "product_ndc": ["0338-0703", "0338-0705", "0338-0709"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["POTASSIUM CHLORIDE"], "rxcui": ["312507", "1860239", "1860241", "1860463", "1860466"], "spl_id": ["662e9982-ba6a-4787-98bd-7f03fbc6c6de"], "spl_set_id": ["092ddee4-572d-4771-8d95-880cea01097e"], "package_ndc": ["0338-0703-41", "0338-0703-48", "0338-0705-41", "0338-0705-48", "0338-0709-48"], "is_original_packager": [true], "unii": ["660YQ98I10"]}, "product_type": "Drugs", "event_id": "69130", "recalling_firm": "Baxter Healthcare Corp", "address_1": "1 Baxter Pkwy", "address_2": "N/A", "postal_code": "60015-4625", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1606-2014", "product_description": "Potassium Chloride Injection, 10 mEq per 100 mL, Highly Concentrated (100 mEq/L), 100 mL Sterile single dose container bags, Rx only, Baxter USA, product code 2B0826, NDC 0338-0709-48.", "product_quantity": "148632 bags", "reason_for_recall": "Correct Labeled Product Mispack: Shipping cartons labeled as containing Potassium Chloride injection actually contained bags labeled and containing Gentamicin Sulfate injection inside.", "recall_initiation_date": "20140908", "center_classification_date": "20140923", "termination_date": "20160927", "report_date": "20141001", "code_info": "Lot P318220, EXP 05/31/15"}, {"status": "Terminated", "city": "Naperville", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69152", "recalling_firm": "Martin Avenue Pharmacy, Inc.", "address_1": "1247 Rickert Dr", "address_2": "N/A", "postal_code": "60540-1008", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0132-2015", "product_description": "Sodium tetradecyl SO4 stock solution 6% solution packaged in an amber glass injectable vial, Martin Avenue Pharmacy, 1247 Rickert Dr, Naperville, IL.", "product_quantity": "1,300 mL", "reason_for_recall": "Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of all compounded sterile preparations within expiry. The recall is being initiated in connection with a recent FDA inspection due to observations associated with certain quality control procedures that present a risk to sterility assurance.", "recall_initiation_date": "20140827", "center_classification_date": "20141029", "termination_date": "20180531", "report_date": "20141105", "code_info": "Lot Number: 05142014@16, Exp 11/10/2014; 07142014@47, Exp 1/10/2015; 07152014@18, Exp 1/11/2015; 08062014@16, Exp 2/2/2015", "more_code_info": ""}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling:Label Mixup; OXcarbazepine Tablet, 600 mg may be potentially mislabeled as    LACTASE ENZYME, Tablet, 3000 units, NDC 24385014976, Pedigree: AD30028_25, EXP: 5/7/2014.", "address_2": "", "product_quantity": "100 Tablets", "code_info": "OXcarbazepine, Tablet, 600 mg has the following code    Pedigree: AD30140_46, EXP: 5/7/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "OXcarbazepine Tablet, 600 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 62756018588", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-674-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Whitehouse Station", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "67344", "recalling_firm": "Merck & Co Inc", "address_1": "1 Merck Dr", "address_2": "P.O. Box 100", "postal_code": "08889-3400", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-1310-2014", "product_description": "Liptruzet (ezetimibe and atorvastin) tablets,10 mg/20 mg, a) 30 count blister    (NDC 66582-321-30), b) 90 count blister  (NDC 66582-321-54), Rx only, Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc, Whitehouse Station, NJ 08889", "product_quantity": "20,259 cartons", "reason_for_recall": "This recall of LIPTRUZET is being initiated due to  packaging defects. Some of the outer laminate foil pouches allowed in air and moisture, which could potentially decrease the effectiveness or change the characteristics of the product.", "recall_initiation_date": "20140113", "center_classification_date": "20140506", "termination_date": "20150902", "report_date": "20140514", "code_info": "a) Liptruzet 10/20mg 30 count, 346353, 346354, Exp. 06/14; 351809, Exp. 07/14, 360530, Exp. 12/14.   b) Liptruzet 10/20mg,  90 count,  346387, Exp. 06/14; 353185, Exp.12/14."}, {"status": "Terminated", "city": "Overland Park", "state": "KS", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69674", "recalling_firm": "Perry Drug Inc.", "address_1": "12200 W 106th St Ste 140", "address_2": "N/A", "postal_code": "66215-2305", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Kansas and Missouri", "recall_number": "D-0268-2015", "product_description": "HCG 200 IU/mL Injection, 30Ml, 10 mL vials, Compounded Rx, Perry Drug Compounding Pharmacy, Overland Park, KS --- NDC 88888-7745-68", "product_quantity": "1 vial", "reason_for_recall": "Lack of sterility assurance;All lots of sterile products compounded by the pharmacy that are within expiry were recalled due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.", "recall_initiation_date": "20141107", "center_classification_date": "20141124", "termination_date": "20151103", "report_date": "20141203", "code_info": "141015DD, 11/15/14", "more_code_info": ""}, {"status": "Terminated", "city": "Ferndale", "state": "WA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "67723", "recalling_firm": "Terra-Medica Inc.", "address_1": "1465 Slater Rd", "address_2": "N/A", "postal_code": "98248-8919", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Products were distributed US Nationwide, to Canada, to Philippines, and through internet sales.", "recall_number": "D-1199-2014", "product_description": "Pleo Nota- Quent DROPS 5X, 10 mL Bottles, Homeopathic Medicine, OTC Only.  Made in Germany, Manufactured by: Sanum-Kehlbeck GmbH & Co. KG, Hoya, Germany.  Distributed by: SANUM USA Corp., 1465 Slater Road, Ferndale, WA 98248. NDC: 49807-0031-1.", "product_quantity": "6120 cartons", "reason_for_recall": "Penicillin Cross Contamination", "recall_initiation_date": "20140303", "center_classification_date": "20140407", "termination_date": "20140730", "report_date": "20140416", "code_info": "Batch #04062 , EXP: May 2017; Batch #06062 , EXP: May 2017."}, {"status": "Terminated", "city": "Overland Park", "state": "KS", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69674", "recalling_firm": "Perry Drug Inc.", "address_1": "12200 W 106th St Ste 140", "address_2": "N/A", "postal_code": "66215-2305", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Kansas and Missouri", "recall_number": "D-0263-2015", "product_description": "Phenylephrine HCl (100 mcg/mL syr) in 0.9% NaCl 1 mg / 10 mL, 3Ml Syringes, Compounded Rx, Perry Drug Compounding Pharmacy, Overland Park, KS --- NDC 88888-5230-12", "product_quantity": "8 prefilled syringes", "reason_for_recall": "Lack of sterility assurance;All lots of sterile products compounded by the pharmacy that are within expiry were recalled due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.", "recall_initiation_date": "20141107", "center_classification_date": "20141124", "termination_date": "20151103", "report_date": "20141203", "code_info": "141008AA, 11/8/14; 141017E, 11/17/14; 141030EE, 11/30/14", "more_code_info": ""}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup; metFORMIN HCl Tablet, 500 mg may be potentially mislabeled as    OMEGA-3 FATTY ACID, Capsule, 1000 mg, NDC 40985022921, Pedigree: AD32742_1, EXP: 5/1/2014.", "address_2": "", "product_quantity": "100 Tablets", "code_info": "metFORMIN HCl, Tablet 500 mg has the following code    Pedigree: AD46312_25, EXP: 5/16/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "metFORMIN HCl Tablet 500 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 23155010201", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-528-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "202 SW 17th St Suite C", "reason_for_recall": "Lack of Assurance of Sterility; All lots of sterile products compounded by the pharmacy within expiry are subject to this recall. This recall is initiated due to concerns associated with quality control procedures observed during a recent FDA inspection.", "address_2": "", "product_quantity": "7", "code_info": "Rx # 29038, Exp 05/20/14", "center_classification_date": "20140724", "distribution_pattern": "Florida", "state": "FL", "product_description": "Cubicin 486 mg/100 mL 0.9%NS, Trinity Care Solutions, 202-C SW 17th Street, Ocala, FL 34471-5138, For Parenteral Use Only, RX # 29038, Discard After 05/20/2014", "report_date": "20140730", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc dba Trinity Care Solutions", "recall_number": "D-1459-2014", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "68497", "more_code_info": "", "recall_initiation_date": "20140515", "postal_code": "34471-8138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Ongoing"}, {"status": "Terminated", "city": "Wilsonville", "state": "OR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69519", "recalling_firm": "Oregon Compounding Centers, Inc. dba Creative Compounds", "address_1": "8560 Sw Salish Ln Ste 100", "address_2": "N/A", "postal_code": "97070-9625", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Oregon, Washington", "recall_number": "D-0214-2015", "product_description": "PAPAVERINE HCL/PHENTOLAMINE/PROSTAGLANDIN, 27.7mg/0.45mg/45.45mcg, injectable, 1.25 mL glass vial, RX, Creative Compounds, Wilsonville, OR 97070", "product_quantity": "5 mL", "reason_for_recall": "Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.", "recall_initiation_date": "20141006", "center_classification_date": "20141031", "termination_date": "20150630", "report_date": "20141112", "code_info": "Lot #: 20140912@25, discard date: 10/27/2014"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: chlorproMAZINE HCl, Tablet, 100 mg may have potentially been mislabeled as one of the following drugs:  ACYCLOVIR, Tablet, 800 mg, NDC 00093894701, Pedigree: AD70629_1, EXP: 5/29/2014;  TRIMETHOBENZAMIDE HCL, Capsule, 300 mg, NDC 53489037601, Pedigree: AD70625_1, EXP: 5/29/2014.", "address_2": "", "product_quantity": "200 Tablets", "code_info": "chlorproMAZINE HCl, Tablet, 100 mg has the following codes:   Pedigree: AD70629_4, EXP: 5/29/2014;  Pedigree: AD70700_1, EXP: 5/29/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "chlorproMAZINE HCl, Tablet, 100 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00832030300.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-1015-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Noblesville", "state": "IN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "68191", "recalling_firm": "Pharmakon Pharmaceuticals", "address_1": "14450 Getz Rd", "address_2": "N/A", "postal_code": "46060-3303", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "United States: TX, IL, MD, IN", "recall_number": "D-1567-2014", "product_description": "Glycopyrrolate 0.2 mg/ml, 5 mL pre-filled syringe, Rx Only.  Pharmakon Pharmaceuticals, Inc., 14450 Getz Rd., Noblesville, IN 46060,  NDC#: 45183-0965-70.", "product_quantity": "200 Syringes", "reason_for_recall": "Incorrect/ Undeclared Excipient: Contains undeclared benzyl alcohol.", "recall_initiation_date": "20140421", "center_classification_date": "20140826", "termination_date": "20141203", "report_date": "20140903", "code_info": "Lot #: E131210.212 Exp: 07/14/2014"}, {"status": "Completed", "city": "Asbury Park", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "68158", "recalling_firm": "Flawless Beauty LLC", "address_1": "1215 Main St", "address_2": "", "postal_code": "07712-5940", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-1319-2014", "product_description": "Relumins Advanced Glutathione (lyophilized glutathione/vitamin C) injectable solution, 1500 mg/500 mg, packaged in 8-count vials, 8-count 5 mL vitamin C (ascorbic acid) solution diluent ampoules, and 30-count Advanced Glutathione Boosters capsules per box, Relumins Labs, 183 Locust Avenue, West Long Branch, NJ 07764, UPC 700175760302", "product_quantity": "unknown", "reason_for_recall": "Marketed Without An Approved NDA/ANDA: Product is sold over the counter whose labeling indicates it is to be used parenterally for drug claims.", "recall_initiation_date": "20140429", "center_classification_date": "20140513", "report_date": "20140521", "code_info": "Lot #: 130616, Exp 06/16", "more_code_info": ""}, {"status": "Terminated", "city": "Toronto", "state": "N/A", "country": "Canada", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "69546", "recalling_firm": "Apotex Inc.", "address_1": "150 Signet Drive", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide.", "recall_number": "D-0241-2015", "product_description": "Candesartan Cilexetil Tablets, 4 mg, 30-count bottle, Rx Only, Manufactured by Apotex Research Pvt. Ltd., Bangalore- 560 099, India, Manufactured for Apotex Corp., Weston, FL 33326, NDC 60505-3618-3", "product_quantity": "13,177 bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications: Out of specification (OOS) results were observed for CAD-II, CAD-V and Total Impurities.", "recall_initiation_date": "20141016", "center_classification_date": "20141106", "termination_date": "20160930", "report_date": "20141112", "code_info": "Lot #: KR3924, KR3926; Exp. 11/15"}, {"status": "Terminated", "city": "Aston", "state": "PA", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "67860", "recalling_firm": "Nova Products, Inc.", "address_1": "5 Mount Pleasant Rd", "address_2": "N/A", "postal_code": "19014-1407", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide to retailers and distributors", "recall_number": "D-1602-2014", "product_description": "XZONE GOLD,  750 mg, one capsule blister pack,  Distributed by: XZONE, Orlando, FL 32789", "product_quantity": "Unknown", "reason_for_recall": "Marketed Without an Approved NDA/ANDA: Nova Products, Inc. of Aston, Pennsylvania is voluntarily recalling XZONE GOLD because FDA laboratory analysis determined that they contain undeclared amounts of sildenafil and tadalafil, active ingredients of FDA-approved drugs used to  treat erectile dysfunction.", "recall_initiation_date": "20140328", "center_classification_date": "20140918", "termination_date": "20150806", "report_date": "20140924", "code_info": "lot# 131110GL", "more_code_info": ""}, {"status": "Terminated", "city": "Wilsonville", "state": "OR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69519", "recalling_firm": "Oregon Compounding Centers, Inc. dba Creative Compounds", "address_1": "8560 Sw Salish Ln Ste 100", "address_2": "N/A", "postal_code": "97070-9625", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Oregon, Washington", "recall_number": "D-0211-2015", "product_description": "PAPAVERINE HCL, with preservative, 30 mg/mL, injectable, 1.25 mL glass vial, RX, Creative Compounds, Wilsonville, OR 97070", "product_quantity": "5 mL", "reason_for_recall": "Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.", "recall_initiation_date": "20141006", "center_classification_date": "20141031", "termination_date": "20150630", "report_date": "20141112", "code_info": "Lot #: 20140903@14/1.25, discard date: 10/18/2014"}, {"status": "Terminated", "city": "Edison", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "68793", "recalling_firm": "Daiichi Sankyo Pharma Development", "address_1": "399 Thornall St", "address_2": "", "postal_code": "08837-2236", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide", "recall_number": "D-1507-2014", "product_description": "Benicar HCT Tablets (olmesartan medoxomil/hydrochlorothiazide) 40 mg/12.5 mg, 30 count bottles, Rx Only, Manufactured for: Daiichi Sankyo, Inc., Parsippany, NJ 07054 --- NDC 65597-106-30", "product_quantity": "86 bottles", "reason_for_recall": "Temperature Abuse; various products were not stored at Controlled Room Temperature as per USP guidelines during shipping.", "recall_initiation_date": "20140712", "center_classification_date": "20140731", "termination_date": "20150316", "report_date": "20140806", "code_info": "Lot #0002073  Exp - 12/31/2016", "more_code_info": ""}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup; LACTOBACILLUS GG Capsule, 15 Billion Cells may be potentially mislabeled as    ASPIRIN EC, Tablet, 325 mg, NDC 00904201360, Pedigree: W003356, EXP: 6/19/2014;  ZONISAMIDE, Capsule, 100 mg, NDC 64679099001, Pedigree: W003786, EXP: 6/27/2014;  VENLAFAXINE HCL, Tablet, 25 mg, NDC 00093019901, Pedigree: W003860, EXP: 6/27/2014.", "address_2": "", "product_quantity": "630 Cells", "code_info": "LACTOBACILLUS GG, Capsule, 15 Billion Cells has the following codes    Pedigree: W003357, EXP: 6/19/2014;  Pedigree: W003787, EXP: 6/27/2014;  Pedigree: W003869, EXP: 6/27/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "LACTOBACILLUS GG Capsule, 15 Billion Cells, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 49100036374", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-581-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling:Label Mixup; MULTIVITAMIN/MULTIMINERAL Tablet may be potentially mislabeled as    OMEGA-3 FATTY ACID, Capsule, 1000 mg, NDC 00904404360, Pedigree: AD62865_13, EXP: 5/23/2014;  guaiFENesin ER, Tablet, 600 mg, NDC 63824000834, Pedigree: W003514, EXP: 6/21/2014.", "address_2": "", "product_quantity": "1,000 Tablets", "code_info": "MULTIVITAMIN/MULTIMINERAL Tablet has the following codes    Pedigree: AD62979_1, EXP: 5/23/2014;  Pedigree: W003553, EXP: 6/24/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "MULTIVITAMIN/MULTIMINERAL Tablet, Distributed by: AidaPak Service, LLC, NDC 65162066850", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-710-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Asheville", "address_1": "752 Biltmore Ave", "reason_for_recall": "Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.", "address_2": "", "product_quantity": "", "code_info": "All lot numbers within expiry.", "center_classification_date": "20140304", "distribution_pattern": "NC", "state": "NC", "product_description": "Bleomycin Sulfate 1unit/ml", "report_date": "20140312", "classification": "Class II", "openfda": {}, "recalling_firm": "Natures Pharmacy & Compounding Center", "recall_number": "D-1102-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "66856", "termination_date": "20140424", "more_code_info": "", "recall_initiation_date": "20131101", "postal_code": "28803-2558", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Farmingdale", "address_1": "65 E Carmans Rd", "reason_for_recall": "Marketed without an Approved NDA/ANDA; product found to contain dimethazine which is a steroid and/or steroid-like drug ingredient, making it an unapproved new drug", "address_2": "", "product_quantity": "5,555 bottles", "code_info": "lot number: L54Q", "center_classification_date": "20140305", "distribution_pattern": "Nationwide", "state": "NY", "product_description": "METHA-DROL Extreme capsules, packaged as 60 capsules per bottle Pro-Anabolic Mass Stack Dietary Supplement, Manufactured for Blackstone Labs, Boca Raton, FL", "report_date": "20140312", "classification": "Class I", "openfda": {}, "recalling_firm": "Mira Health Products Ltd.", "recall_number": "D-1151-2014", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "65772", "termination_date": "20140915", "more_code_info": "", "recall_initiation_date": "20130722", "postal_code": "11735-3834", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Ferndale", "state": "WA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "67723", "recalling_firm": "Terra-Medica Inc.", "address_1": "1465 Slater Rd", "address_2": "N/A", "postal_code": "98248-8919", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Products were distributed US Nationwide, to Canada, to Philippines, and through internet sales.", "recall_number": "D-1209-2014", "product_description": "Pleo Ex SUPPOSITORIES 3X, 10 Suppository Packages; Homeopathic Antifungal Medicine, OTC Only.  Made in Germany. Distributed by: SANUM USA Corp., 1465 Slater Road, Ferndale, WA 98248.  Manufactured by: Sanum-Kehlbeck GmbH & Co. KG.  NDC: 49807-1001-1.", "product_quantity": "5940 Packages", "reason_for_recall": "Penicillin Cross Contamination", "recall_initiation_date": "20140303", "center_classification_date": "20140407", "termination_date": "20140730", "report_date": "20140416", "code_info": "Batch # 2011; EXP: December 2015; Batch # 2081, EXP: July 2016; Batch # 3063, EXP: May  2018; Batch # 1013, EXP: February  2018."}, {"status": "Terminated", "city": "Wilsonville", "state": "OR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69519", "recalling_firm": "Oregon Compounding Centers, Inc. dba Creative Compounds", "address_1": "8560 Sw Salish Ln Ste 100", "address_2": "N/A", "postal_code": "97070-9625", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Oregon, Washington", "recall_number": "D-0190-2015", "product_description": "GANCICLOVIR -preservative free, 2mg/0.1mL, injectable, 0.1 mL plastic syringe, RX, Creative Compounds, Wilsonville, OR 97070", "product_quantity": "40 syringes", "reason_for_recall": "Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.", "recall_initiation_date": "20141006", "center_classification_date": "20141031", "termination_date": "20150630", "report_date": "20141112", "code_info": "Lot #: 20140916@16, discard date: 10/31/2014"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling:Label Mixup; ISOSORBIDE MONONITRATE ER Tablet, 30 mg may be potentially mislabeled as    LOSARTAN POTASSIUM, Tablet, 25 mg, NDC 16714058102, Pedigree: W003899, EXP: 6/27/2014;  MISOPROSTOL, Tablet, 100 mcg, NDC 43386016012, Pedigree: AD42611_7, EXP: 5/14/2014;  hydrOXYzine PAMOATE, Capsule, 100 mg, NDC 00555032402, Pedigree: W003332, EXP: 6/18/2014;  glyBURIDE, Tablet, 2.5 mg, NDC 0009383", "address_2": "", "product_quantity": "700 Tablets", "code_info": "ISOSORBIDE MONONITRATE ER Tablet, 30 mg has the following codes    Pedigree: W003996, EXP: 7/1/2014;  Pedigree: AD46297_1, EXP: 5/15/2014;  Pedigree: W003350, EXP: 6/18/2014;  Pedigree: AD21790_64, EXP: 5/1/2014;  Pedigree: AD32757_37, EXP: 5/14/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "ISOSORBIDE MONONITRATE ER Tablet, 30 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 62175012837", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-671-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Upper Saddle River", "address_1": "58 Ware Rd", "reason_for_recall": "CGMP Deviations: The Active Pharmaceutical Ingredient was not manufactured according to current good manufacturing practices.", "address_2": "", "product_quantity": "27,000 kilos (1080 drums)", "code_info": "Lot #: DMFH-366/11, DMFH-367/11, DMFH-368/11, DMFH-369/11, DMFH-370/11, DMFH-371/11, DMFH-372/11, DMFH-373/11, DMFH-374/11, DMFH-375/11, DMFH-376/11, DMFH-393/11, DMFH-394/11, DMFH-395/11, DMFH-396/11, DMFH-397/11, DMFH-399/11, DMFH-400/11, DMFH-401/11, DMFH-402/11, DMFH-403/11, DMFH-404/11, DMFH-405/11, DMFH-406/11", "center_classification_date": "20140110", "distribution_pattern": "MO", "state": "NJ", "product_description": "Metformin Hydrochloride USP, Active Pharmaceutical Ingredient for manufacturing, processing or re-packing use only, 25 kg drum, Rx only, Manufactured by: Smruthi Organics Limited, Plot No.: A-27 M.I.D.C., Chincholi, Taq.: Mohol, Solapur-413 255. Maharashtra, India; NDC No. 10828-002-06, Cas No: 1115-70-4", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Betachem, Inc.", "recall_number": "D-406-2014", "initial_firm_notification": "E-Mail", "product_type": "Drugs", "event_id": "67155", "termination_date": "20170807", "more_code_info": "", "recall_initiation_date": "20131007", "postal_code": "07458-1922", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup; LACTASE ENZYME Tablet, 3000 units may be potentially mislabeled as    BENZOCAINE/MENTHOL, LOZENGE, 15 mg/3.6 mg, NDC 63824072016, Pedigree: AD21811_4, EXP: 5/1/2014;  ACETAMINOPHEN/ ASPIRIN/ CAFFEINE, Tablet, 250 mg/250 mg/65 mg, NDC 46122010478, Pedigree: W003722, EXP: 4/30/2014;  guaiFENesin ER, Tablet, 600 mg, NDC 45802049878, Pedigree: AD30140_37, EXP: 5/7/2014;  CALCIUM", "address_2": "", "product_quantity": "2,872 Tablets", "code_info": "LACTASE ENZYME Tablet, 3000 units has the following codes    Pedigree: AD21846_31, EXP: 5/1/2014;  Pedigree: W003721, EXP: 6/26/2014;  Pedigree: AD30028_25, EXP: 5/7/2014;  Pedigree: AD60240_36, EXP: 5/22/2014;  Pedigree: W002700, EXP: 6/5/2014;  Pedigree: AD46257_53, EXP: 5/15/2014;  Pedigree: W003021, EXP: 6/12/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "LACTASE ENZYME Tablet, 3000 units, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 24385014976", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-537-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: DIGOXIN, Tablet, 125 mcg may have potentially been mislabeled as the following drug:  CHOLECALCIFEROL/ CALCIUM/ PHOSPHORUS, Tablet, 120 units/105 mg/81 mg, NDC 64980015001, Pedigree: W002581, EXP: 6/3/2014.", "address_2": "", "product_quantity": "200 Tablets", "code_info": "DIGOXIN, Tablet, 125 mcg has the following codes:   Pedigree: AD76675_4, EXP: 6/3/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "DIGOXIN, Tablet, 125 mcg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00527132401.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-919-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup;  PHYTONADIONE Tablet, 5 mg may be potentially mislabeled as    medroxyPROGESTERone ACETATE, Tablet, 10 mg, NDC 59762374202, Pedigree: AD46312_19, EXP: 5/16/2014;  HYDROCORTISONE, Tablet, 5 mg, NDC 00603389919, Pedigree: W003060, EXP: 6/12/2014;  GALANTAMINE HBR ER, Capsule, 24 mg, NDC 47335083783, Pedigree: W003735, EXP: 5/31/2014;  TORSEMIDE, Tablet, 10 mg, NDC 31722053001,", "address_2": "", "product_quantity": "500 Tablets", "code_info": "PHYTONADIONE Tablet, 5 mg has the following codes    Pedigree: AD46312_22, EXP: 4/30/2014;  Pedigree: W003061, EXP: 5/31/2014;  Pedigree: W003737, EXP: 5/31/2014;  Pedigree: AD25452_1, EXP: 4/30/2014;  Pedigree: W003440, EXP: 5/31/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "PHYTONADIONE Tablet, 5 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 25010040515", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-541-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: CETIRIZINE HCL, Tablet, 5 mg may have potentially been mislabeled as the following drug:  LITHIUM CARBONATE ER, Tablet, 300 mg, NDC 00054002125, Pedigree: AD39564_1, EXP: 5/13/2014.", "address_2": "", "product_quantity": "100 Tablets", "code_info": "CETIRIZINE HCL, Tablet, 5 mg has the following codes:   Pedigree: AD32757_13, EXP: 5/13/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "CETIRIZINE HCL, Tablet, 5 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00378363501.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-906-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69553", "recalling_firm": "Actavis Inc", "address_1": "400 Interpace Pkwy", "address_2": "N/A", "postal_code": "07054-1120", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0232-2015", "product_description": "Vancomycin Hydrochloride Capsule, USP, 125 mg, 20 count blister pack, Rx Only, Mfd. for: Watson Pharma. Inc. Parsippany, NJ 07054 USA, Mfd. by: Patheon Pharmaceuticals Inc. Cincinnati, OH 45237 USA ---- NDC 0591-3560-15 UPC Code 3-0591356015-4", "product_quantity": "26,663 cartons", "reason_for_recall": "Subpotent Drug", "recall_initiation_date": "20140825", "center_classification_date": "20141030", "termination_date": "20180321", "report_date": "20141105", "code_info": "3103681, exp Aug 2014,  3104886, exp Oct 2014,  3105836, exp Dec 2014, and  3106650, exp Dec 2014", "more_code_info": ""}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA090383"], "brand_name": ["SIMVASTATIN"], "generic_name": ["SIMVASTATIN"], "manufacturer_name": ["Micro Labs Limited"], "product_ndc": ["42571-005", "42571-010", "42571-020", "42571-040", "42571-080"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["SIMVASTATIN"], "rxcui": ["198211", "200345", "312961", "312962", "314231"], "spl_id": ["0369d423-9ef2-0191-e063-6294a90a55e7"], "spl_set_id": ["5c1c694c-4b08-469e-b538-08e69df06146"], "package_ndc": ["42571-010-30", "42571-010-60", "42571-010-90", "42571-010-05", "42571-010-10", "42571-005-30", "42571-005-60", "42571-005-90", "42571-005-05", "42571-005-10", "42571-020-30", "42571-020-60", "42571-020-90", "42571-020-05", "42571-020-10", "42571-040-30", "42571-040-60", "42571-040-90", "42571-040-05", "42571-040-10", "42571-080-30", "42571-080-60", "42571-080-90", "42571-080-05", "42571-080-10"], "is_original_packager": [true], "upc": ["0342571010300", "0342571040307", "0342571020309", "0342571005306", "0342571080303"], "nui": ["N0000175589", "N0000000121"], "pharm_class_epc": ["HMG-CoA Reductase Inhibitor [EPC]"], "pharm_class_moa": ["Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]"], "unii": ["AGG2FN16EV"]}, "product_type": "Drugs", "event_id": "69268", "recalling_firm": "Micro Labs Usa, Inc                                    S", "address_1": "104 Carnegie Ctr", "address_2": "Te 216", "postal_code": "08540-6232", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "NY", "recall_number": "D-0246-2015", "product_description": "Simvastatin Tablets, USP, 10 mg, Rx Only, 90 count bottles, Manufactured by: Micro Labs Limited, Goa-403 722, INDIA, Manufactured for: Micro Labs USA Inc., Princeton, NJ 08540, NDC 42571-010-90", "product_quantity": "1,008 bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications: Product failed Impurity content (Butylated Hydroxy Anisole Content) against shelf life specification.", "recall_initiation_date": "20140819", "center_classification_date": "20141112", "termination_date": "20160419", "report_date": "20141119", "code_info": "Lot #: STBG005, Exp 2/2015", "more_code_info": ""}, {"status": "Terminated", "city": "Aiken", "state": "SC", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "67800", "recalling_firm": "GlaxoSmithKline Consumer Healthcare; dba-GlaxoSmithKline", "address_1": "65 Windham Blvd", "address_2": "N/A", "postal_code": "29805-9384", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-1244-2014", "product_description": "Nicorette Lozenge,  Nicoderm CQ, and Nicorette Gum nicotine polacrilex combination.  Contains 30 Pieces/ Pallet.  OTC only.  GlaxoSmithKlein, 1000 GSK Drive, Moon Township, PA 15108. UPC: 0-03-0766-1442-81-2.", "product_quantity": "12,162 Pallets", "reason_for_recall": "Failed Lozenge Specifications; Lozenges are overly thick, overly soft, and sub and superpotent.", "recall_initiation_date": "20140220", "center_classification_date": "20140418", "termination_date": "20170120", "report_date": "20140430", "code_info": "Lot #12K16W (exp 5/14), 12K27N (exp 6/14), 12K27W (exp 6/14), 12K29N (exp 6/14), 13K20W (exp 6/15), 13K20W1 (exp 6/15) & 13K25N (exp 6/15).", "more_code_info": ""}, {"status": "Terminated", "city": "Overland Park", "state": "KS", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69674", "recalling_firm": "Perry Drug Inc.", "address_1": "12200 W 106th St Ste 140", "address_2": "N/A", "postal_code": "66215-2305", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Kansas and Missouri", "recall_number": "D-0267-2015", "product_description": "HCG Low Dose 10 IU / 0.1 mL, 5 Ml vials, Compounded Rx, Perry Drug Compounding Pharmacy, Overland Park, KS ---NDC 88888-2596-17", "product_quantity": "2 vials", "reason_for_recall": "Lack of sterility assurance;All lots of sterile products compounded by the pharmacy that are within expiry were recalled due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.", "recall_initiation_date": "20141107", "center_classification_date": "20141124", "termination_date": "20151103", "report_date": "20141203", "code_info": "141010I, 11/10/14; 141017F, 11/17/14;", "more_code_info": ""}, {"status": "Terminated", "city": "Williamstown", "state": "NJ", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "66406", "recalling_firm": "Haute Health, LLC", "address_1": "614 Atlanta Ct", "address_2": "N/A", "postal_code": "08094-3549", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide and internationally via internet sales.", "recall_number": "D-1235-2014", "product_description": "Prolifta Dietary Supplement Prolifta, 400mg/capsule, Packaged in 1 and 2 capsule blister packs and 4, 12, and 24 capsule bottles   Made in the USA Distributed by: Prolifta LLC 1+877.239.8231  www.proliftaherbal.com.", "product_quantity": "172,800 capsules", "reason_for_recall": "Marketed without an Approved NDA/ANDA: Dietary supplement may contain amounts of an active ingredient found in some FDA-approved drugs for erectile dysfunction (ED) making the dietary supplement an unapproved drug.", "recall_initiation_date": "20130927", "center_classification_date": "20140415", "termination_date": "20150129", "report_date": "20140423", "code_info": "All lot codes and expiration dates."}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: SODIUM CHLORIDE, Tablet, 1000 mg may have potentially been mislabeled as the following drug:  REPAGLINIDE, Tablet, 2 mg, NDC 00169008481, Pedigree: W003925, EXP: 7/1/2014.", "address_2": "", "product_quantity": "1000 Tablets", "code_info": "SODIUM CHLORIDE, Tablet, 1000 mg has the following codes:   Pedigree: W003925, EXP: 7/1/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "SODIUM CHLORIDE, Tablet, 1000 mg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00527111610", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-918-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Columbus", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "67881", "recalling_firm": "American Health Packaging", "address_1": "2550 John Glenn Ave", "address_2": "Suite A", "postal_code": "43217-1188", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1188-2014", "product_description": "HydrOXYzine HCl Tablets, USP  25 mg, 100 Tablet Blister, Rx only Mfd by: KVK-TECH, INC. Newtown, PA 18940, NDC 68084-254-01", "product_quantity": "14,665 blister packs", "reason_for_recall": "Good Manufacturing Practices Deviations: The product has an active pharmaceutical ingredient from an  unapproved source.", "recall_initiation_date": "20140131", "center_classification_date": "20140403", "termination_date": "20150401", "report_date": "20140409", "code_info": "Lot 120407, Exp 01/14; Lot 121337 Exp 03/14; Lot 122054, Exp 05/14; Lot  122598, Exp 06/14;   Lot 130125, Exp 12/14"}, {"status": "Terminated", "city": "Eatontown", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69539", "recalling_firm": "West-Ward Pharmaceutical Corp.", "address_1": "465 Industrial Way W", "address_2": "N/A", "postal_code": "07724-2209", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "GA", "recall_number": "D-0172-2015", "product_description": "VERSAPHARM INCORPORATED Ethambutol Hydrochloride Tablets, USP, 100 mg, 100-count bottle, Rx Only, Manufactured for VersaPharm Incorporated Marietta, GA 30065-1509 Manufactured by West-ward Pharmaceutical Corp. Eatontown, NJ 07724, NDC 61748-011-01", "product_quantity": "5,596 HDPE bottles", "reason_for_recall": "Subpotency: Out of Specification (OOS) result at the 36 month routine stability time point.", "recall_initiation_date": "20141002", "center_classification_date": "20141030", "termination_date": "20150803", "report_date": "20141105", "code_info": "Lot #68975A, #68976; Exp. 07/15", "more_code_info": ""}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup; LACTOBACILLUS GG Capsule may be potentially mislabeled as    VITAMIN B COMPLEX W/C, Capsule, NDC 54629008001, Pedigree: AD39560_4, EXP: 5/13/2014;  DOCUSATE SODIUM, Capsule, 50 mg, NDC 67618010060, Pedigree: AD65457_13, EXP: 5/24/2014;  VITAMIN B COMPLEX WITH C/FOLIC ACID, Tablet, NDC 60258016001, Pedigree: AD70655_17, EXP: 5/28/2014;  TACROLIMUS, Capsule, 1 mg, NDC 00781210", "address_2": "", "product_quantity": "1,970 Capsules", "code_info": "LACTOBACILLUS GG, Capsule has the following codes    Pedigree: AD39588_4, EXP: 5/13/2014  Pedigree: AD65457_16, EXP: 5/24/2014  Pedigree: AD70655_8, EXP: 5/29/2014  Pedigree: AD73627_17, EXP: 5/30/2014  Pedigree: W003051, EXP: 6/12/2014  Pedigree: W003216, EXP: 6/14/2014  Pedigree: AD42584_12, EXP: 5/14/2014  Pedigree: AD46300_11, EXP: 5/15/2014  Pedigree: W002968, EXP: 6/11/2014  Pedigree: AD68019_1, EXP: 5/28/2014  Pedigree: W003172, EXP: 6/13/2014  Pedigree: W003173, EXP: 6/13/2014", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "LACTOBACILLUS GG Capsule, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 49100036374", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-579-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup; SODIUM BICARBONATE Tablet, 650 mg may be potentially mislabeled as    NICOTINE POLACRILEX, Lozenge, 2 mg, NDC 00135051001, Pedigree: W002974, EXP: 6/11/2014.", "address_2": "", "product_quantity": "1,013 Tablets", "code_info": "SODIUM BICARBONATE Tablet, 650 mg has the following code    Pedigree: W002970, EXP: 6/11/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "SODIUM BICARBONATE Tablet, 650 mg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 64980018210", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-704-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling:Label Mixup; SEVELAMER HCl Tablet, 800 mg may be potentially mislabeled as    RANOLAZINE ER, Tablet, 500 mg, NDC 61958100301, Pedigree: W002857, EXP: 6/7/2014.", "address_2": "", "product_quantity": "180 Tablets", "code_info": "SEVELAMER HCl Tablet, 800 mg has the following code    Pedigree: W002858, EXP: 6/7/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "SEVELAMER HCl Tablet, 800 mg, Rx only, Distributed by: AidaPak Service, LLC,  NDC 58468002101", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-636-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Nashville", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "68557", "recalling_firm": "John W Hollis Inc", "address_1": "110 20th Ave N", "address_2": "N/A", "postal_code": "37203-2315", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide", "recall_number": "D-1395-2014", "product_description": "Levocarnitine Solution for injection, l-Carnitine 50 mg, Also Contains Sterile Water for Injection and Benzyl Alcohol pH adjusted with HCl, 50 mL, JOHN HOLLIS Pharmacist, Inc. 110 20th Avenue N, Nashville, TN 37203, 615-327-3234", "product_quantity": "1750 mL", "reason_for_recall": "Lack of Assurance of Sterility: Lack of sterility assurance in compounded aseptically filled injectable products.", "recall_initiation_date": "20140512", "center_classification_date": "20140618", "termination_date": "20140702", "report_date": "20140625", "code_info": "Lot: 1731, Use by 7/01/14; Lot: 2190, Use by 8/24/14", "more_code_info": ""}, {"country": "United States", "city": "South Lyon", "address_1": "350 S Lafayette St", "reason_for_recall": "Lack of Assurance of Sterility: All unexpired sterile compounded human and veterinary products are being recalled because they were compounded in the same environment and under the same practices as another product found to be non-sterile and therefore sterility cannot be assured.", "address_2": "", "product_quantity": "11 mL", "code_info": "All unexpired lots, manufactured and distributed between 07/01/2013 and 10/19/2013; including Lot #: 07232013@41", "center_classification_date": "20140110", "distribution_pattern": "Hospitals, clinics, physicians, and patients in the Michigan area only.", "state": "MI", "product_description": "Phenol, 6%, Injectable, Rx only, Specialty Medicine Compounding Pharmacy, 350 S Lafayette, South Lyon, MI 48178", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Specialty Medicine Compounding Pharmacy", "recall_number": "D-438-2014", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "66566", "termination_date": "20140922", "more_code_info": "", "recall_initiation_date": "20131019", "postal_code": "48178-1814", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup; WARFARIN SODIUM, Tablet, 0.5 mg (1/2 of 1 mg) may be potentially mislabeled as    SODIUM CHLORIDE, Tablet, 1 mg, NDC 00223176001, Pedigree: AD70636_1, EXP: 5/29/2014.", "address_2": "", "product_quantity": "200 Tablets", "code_info": "WARFARIN SODIUM, Tablet, 0.5 mg (1/2 of 1 mg) has the following code    Pedigree: AD60590_4, EXP: 5/29/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "WARFARIN SODIUM Tablet, 0.5 mg (1/2 of 1 mg), Rx only, Distributed by: AidaPak Service, LLC, NDC 51672402701", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-602-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Naperville", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69152", "recalling_firm": "Martin Avenue Pharmacy, Inc.", "address_1": "1247 Rickert Dr", "address_2": "N/A", "postal_code": "60540-1008", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0103-2015", "product_description": "Morphine sulfate (PF) 20 mg/mL injectable packaged in 30 mL or 60 mL syringes, Martin Avenue Pharmacy, 1247 Rickert Dr, Naperville, IL.", "product_quantity": "40 mL", "reason_for_recall": "Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of all compounded sterile preparations within expiry. The recall is being initiated in connection with a recent FDA inspection due to observations associated with certain quality control procedures that present a risk to sterility assurance.", "recall_initiation_date": "20140827", "center_classification_date": "20141029", "termination_date": "20180531", "report_date": "20141105", "code_info": "Lot Number: 07302014@31, Exp 10/28/2014", "more_code_info": ""}, {"status": "Terminated", "city": "Wilsonville", "state": "OR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69519", "recalling_firm": "Oregon Compounding Centers, Inc. dba Creative Compounds", "address_1": "8560 Sw Salish Ln Ste 100", "address_2": "N/A", "postal_code": "97070-9625", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Oregon, Washington", "recall_number": "D-0178-2015", "product_description": "BEVACIZUMAB/DEXAMETHASONE, 1.25/0.5 mL, Injectable, 0.05 mL plastic syringe, RX, Creative Compounds, Wilsonville, OR 97070.", "product_quantity": "2.65 mL", "reason_for_recall": "Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.", "recall_initiation_date": "20141006", "center_classification_date": "20141031", "termination_date": "20150630", "report_date": "20141112", "code_info": "Lot #: 20140916@3, discard date: 12/15/2014."}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: DEXAMETHASONE, Tablet, 1 mg may have potentially been mislabeled as the following drug:  VENLAFAXINE HCL ER, Capsule, 150 mg, NDC 00093738656, Pedigree: AD30993_20, EXP: 5/9/2014.", "address_2": "", "product_quantity": "100 Tablets", "code_info": "DEXAMETHASONE, Tablet, 1 mg has the following codes:   Pedigree: AD37088_1, EXP: 5/9/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "DEXAMETHASONE, Tablet, 1 mg, Rx only, Distributed by Aidapack Service, LLC, NDC 00054418125.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-798-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA019339"], "brand_name": ["HEPARIN SODIUM AND DEXTROSE"], "generic_name": ["HEPARIN SODIUM"], "manufacturer_name": ["Hospira, Inc."], "product_ndc": ["0409-4520", "0409-7793", "0409-7794"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["HEPARIN SODIUM"], "rxcui": ["1658717"], "spl_id": ["0fb90002-cf4c-4da3-9cca-ea8b1394d34c"], "spl_set_id": ["eede8a0c-5ae6-4166-84b3-12081405f08e"], "package_ndc": ["0409-7793-52", "0409-7793-62", "0409-7793-13", "0409-7793-23", "0409-7794-52", "0409-7794-62", "0409-4520-02", "0409-4520-30"], "is_original_packager": [true], "unii": ["ZZ45AB24CA"]}, "product_type": "Drugs", "event_id": "68631", "recalling_firm": "Hospira Inc.", "address_1": "275 N Field Dr", "address_2": "", "postal_code": "60045-2579", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1425-2014", "product_description": "Heparin Sodium in 5% Dextrose Injection, Heparin, 25,000 USP Heparin Units/250 mL (100 USP Heparin Units/mL), 250 mL, Single-Dose Container, Hospira, Inc., Lake Forest, IL 60045 USA,  NDC 0409-7793-62", "product_quantity": "142,152 bags", "reason_for_recall": "Lack of Assurance of Sterility: Confirmed consumer report of fluid leaking from primary container of bag.", "recall_initiation_date": "20140606", "center_classification_date": "20140709", "termination_date": "20150403", "report_date": "20140716", "code_info": "Lot # 34-811-KL, 36-106-KL, 36-114-KL; Exp. 12/15; 36-101-KL, Exp. 12/15; 37-202-KL, Exp. 1/16; 38-302-KL, Exp. 2/16; 38-305-KL, Exp. 2/16", "more_code_info": ""}, {"country": "United States", "city": "Columbus", "address_1": "2550 John Glenn Ave", "reason_for_recall": "Failed USP Dissolution Test Requirements: This sub-recall is in response to Prometheus Laboratories Inc. recall for Mercaptopurine USP 50mg because the lot does not meet the specification for dissolution.", "address_2": "Suite A", "product_quantity": "3496 cartons", "code_info": "Lot #: 142450 Exp 05/2015; 140862 Exp 02/2015; 141596 Exp 03/2015; 134770 Exp 01/2015", "center_classification_date": "20141216", "distribution_pattern": "Nationwide.", "state": "OH", "product_description": "Mercaptopurine Tablets, USP, 50 mg, 30 Tablets (3 x 10) unit dose blisters per carton, Rx only, Manufactured by Prometheus Laboratories Inc. 9410 Carroll Park Drive, San Diego, CA 92121, repackaged by American Health Packaging 2550-A John Glenn Avenue, Columbus, OH 43217, NDC 68084-325-21", "report_date": "20141224", "classification": "Class II", "openfda": {}, "recalling_firm": "American Health Packaging", "recall_number": "D-0300-2015", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "69972", "termination_date": "20150601", "recall_initiation_date": "20141119", "postal_code": "43217-1188", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: PERPHENAZINE, Tablet, 16 mg may have potentially been mislabeled as one of the following drugs:  LITHIUM CARBONATE ER, Tablet, 450 mg, NDC 00054002025, Pedigree: AD21790_28, EXP: 5/1/2014;  LITHIUM CARBONATE ER, Tablet, 450 mg, NDC 00054002025, Pedigree: W002730, EXP: 6/6/2014;  RALTEGRAVIR, Tablet, 400 mg, NDC 00006022761, Pedigree: W003680, EXP: 6/25/2014;  VENLAFAXINE HCL", "address_2": "", "product_quantity": "1200 Tablets", "code_info": "PERPHENAZINE, Tablet, 16 mg has the following codes:   Pedigree: AD21790_31, EXP: 5/1/2014;  Pedigree: W002731, EXP: 6/6/2014;  Pedigree: W003682, EXP: 6/25/2014;  Pedigree: AD73525_22, EXP: 5/30/2014;  Pedigree: W003328, EXP: 6/19/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "PERPHENAZINE, Tablet, 16 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00781104901.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-998-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Romeoville", "state": "IL", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "69611", "recalling_firm": "Nanophase Technologies Corporation", "address_1": "1319 Marquette Dr", "address_2": "N/A", "postal_code": "60446-4055", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "NJ", "recall_number": "D-0238-2015", "product_description": "Z-COTE HP 1 TRANSPARENT ZINC OXIDE, Zinc Oxide (and) Triethoxycaprylylsilane, Powder, NET: 22 KG, Packaged in double plastic liners in a single fiber carton, FOR MANUFACTURING, PROCESSING OR REPACKING, BASF Corporation, Florham Park, NJ", "product_quantity": "1,596 Kg", "reason_for_recall": "cGMP Deviation; The incorrect amount of a raw material was added during the manufacture of two lots of Z-COTE HP 1.", "recall_initiation_date": "20141020", "center_classification_date": "20141106", "termination_date": "20150611", "report_date": "20141112", "code_info": "Lot Codes: CNNI2901, CNNI2902"}]